Bone Marrow TransplantationTransplantation, AutologousBone MarrowBone Marrow CellsTransplantation, HomologousHematopoietic Stem Cell TransplantationBone and BonesGraft vs Host DiseaseTransplantation ConditioningLiver TransplantationWhole-Body IrradiationBone Marrow PurgingGraft SurvivalHematopoietic Stem CellsStem Cell TransplantationLeukemiaKidney TransplantationTransplantation ChimeraAnemia, AplasticBusulfanCombined Modality TherapyBone Marrow DiseasesCyclophosphamideMultiple MyelomaTissue DonorsTreatment OutcomeRecurrenceHematopoiesisBone Marrow ExaminationBone RemodelingLymphoma, Non-HodgkinMelphalanRemission InductionHistocompatibility TestingTransplantation, IsogeneicBone Marrow NeoplasmsTime FactorsHistocompatibilityHeart TransplantationHematologic NeoplasmsHematopoietic Stem Cell MobilizationAntigens, CD34Mice, Inbred C57BLLeukemia, Myeloid, AcuteImmunosuppressive AgentsPeripheral Blood Stem Cell TransplantationGraft RejectionCarmustineAntineoplastic Combined Chemotherapy ProtocolsColony-Forming Units AssayGranulocyte Colony-Stimulating FactorCell TransplantationLung TransplantationSurvival AnalysisRadiation ChimeraTransplantation ImmunologyRetrospective StudiesBone DensityCell DifferentiationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic SyndromesDisease-Free SurvivalSalvage TherapyCells, CulturedEtoposideImmunosuppressionCytarabineT-LymphocytesPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival RateOrgan TransplantationLeukemia, MyeloidFollow-Up StudiesHodgkin DiseaseBone ResorptionGraft vs Tumor EffectFlow CytometryAcute DiseaseHepatic Veno-Occlusive DiseaseLymphocyte DepletionBlood Transfusion, AutologousGraft vs Host ReactionLymphomaCell SeparationHLA AntigensChimeraLeukocyte TransfusionPrognosisCyclosporineBone NeoplasmsHematologic DiseasesSevere Combined ImmunodeficiencyIslets of Langerhans TransplantationPancreas TransplantationSpleenLeukapheresisStem CellsActuarial AnalysisAntibodies, MonoclonalLymphocyte Transfusion